Alzamend Neuro, Inc. (ALZN) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-04-16

Key Insights

Milton C. Ault III, the Executive Chairman of Hyperscale Data, Inc., has increased his beneficial ownership in Alzamend Neuro, Inc. (ALZN) by acquiring 108,388 shares on April 14, 2026.
Ault Lending, LLC, a wholly-owned subsidiary of Hyperscale Data, Inc., holds a significant indirect beneficial ownership stake in Alzamend Neuro, Inc. (ALZN).
Ault Life Sciences, Inc. and Ault Life Sciences Fund, LLC, which are affiliated with Milton C. Ault III, also hold small indirect beneficial ownership stakes in Alzamend Neuro, Inc. (ALZN).

Want the newest filings?

This analysis covers the filing from 2026-04-16. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2025-12-30

Insider Milton C. Ault III sold 1,851 shares of Alzamend Neuro, Inc. (ALZN) at $2.0665 per share, reducing his direct ownership to 0 shares.
Ault Lending, LLC, Ault Life Sciences, Inc., and Ault Life Sciences Fund, LLC, entities controlled by Milton C. Ault III, continue to hold a total of 19,389 shares of ALZN indirectly.
The insider sale appears to be for the purpose of realizing tax losses, as indicated by the filing.

Other reports for Alzamend Neuro, Inc.

Current Report Quarterly Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.